Varian Medical Systems (VAR) : Traders are bullish on Varian Medical Systems (VAR) as it has outperformed the S&P 500 by a wide margin of 0.88% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 1.53%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.87% in the last 1 week, and is up 0.67% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
Company shares have received an average consensus rating of Hold for the current week The stock has recorded a twenty day Moving Average of 0.71% and the fifty day Moving Average is 7.73%. Varian Medical Systems, Inc. is up 16.23% in the last three month period. Year-to-Date the stock performance stands at 18.03%.
Varian Medical Systems (VAR) : The highest short term price target forecast on Varian Medical Systems (VAR) is $102 and the lowest target price is $86. A total of 5 equity analysts are currently covering the company. The average price of all the analysts is $93.4 with a standard deviation of $6.47.
Varian Medical Systems (NYSE:VAR): stock turned positive on Friday. Though the stock opened at $94.91, the bulls momentum made the stock top out at $95.42 level for the day. The stock recorded a low of $94.41 and closed the trading day at $95.37, in the green by 0.77%. The total traded volume for the day was 455,764. The stock had closed at $94.64 in the previous days trading.
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.